The Scottish Intercollegiate Guidelines Network
[Press Release]

SIGN home
New from SIGN
SIGN Update
Guidelines
Published Guidelines
Propose a Guideline
Guidelines by Topic
Guideline Programme
Draft guidelines
e-Books
Methodology
Development process
Checklists
SIGN 50
Online Tutorials
About SIGN
General  Information
Contacts
Location Map
Press releases
Links
SIGN Events
National meetings
Appraisal courses
Other events
Patient involvement
Patient Network
Patient resources
Joining a group

Search SIGN

Guidelines International Network

Scotland's Health on the Web
Scottish Intercollegiate Guidelines Network, 28 Thistle Street, Edinburgh EH2 1EN
Tel. 0131 718 5090
Fax. 0131 718 5114
Web contact duncan.service@nhs.net
Last modified 17/08/06
© SIGN 2001-2006

For Immediate Use 09.30 Thursday 3 November

Attn: Newsdesks
Health Correspondents

Revised national guidelines launched to cut attacks and prevent deaths from asthma

Health professionals throughout the UK will be advised to look at a possible diagnosis of work-related asthma in all adults with symptoms of limited airflow or where childhood asthma reappears, as part of a series of new recommendations made in updated national guidelines launched today.

The updated recommendations developed jointly by the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) are the result of detailed work to provide health professionals with a ‘living guideline’ based on the latest research. The recommendations are designed to improve the quality of treatment provided to the UK’s estimated 5.2 million asthma sufferers (1 in 12 adults).

The guidelines say that patients suspected to be suffering from work-related asthma – the UK’s fastest growing occupational disease – should be promptly referred to a respiratory physician or occupational physician. GPs and specialists are recommended to identify from consultations whether symptoms improve on days away from work or on holiday or get worse when at work. It also states that diagnosis of occupational asthma should be made using air flow measurements, with at least four readings per day, and that relocation away from exposure should occur as soon as diagnosis is confirmed, ideally within 12 months of the first work-related symptoms of asthma.

Other recommendations include:

  • Pressurised metered dose inhalers (pMDI) and spacers are ‘at least as good’ as a nebuliser at treating mild and moderate asthma. Previous research has suggested that nebulisers have no advantages over a pressurised inhaler
  • For patients with both mild and acute asthma, self-management plans should be used. Evidence shows that mailing a partly completed or blank self-management plan, with an invitation for asthma check-up, can double the changes of a patient attending. A new template is included in the guidance

Commenting as the update went live, Dr Graham Douglas of SIGN and consultant at Aberdeen Royal Infirmary said:

“Healthcare professionals and patients benefit from authoritative national guidelines, but it can be far from straightforward ensuring that these keep abreast of new findings. This second annual update to the national asthma guidelines published in 2003 shows that there is a real commitment to maintaining a ‘living guideline’ and that where before there may have been peaks of interest the updates justify this staying at a high level. Users can quickly see through colour coding how the updates are shaping the guideline.

Dr Bernard Higgins, member of the British Thoracic Society and consultant physician at the Freeman Hospital in Newcastle, commented:

“Work-related asthma is the UK’s fastest growing occupational disease and the guidance prompts all health care professionals to be aware of this possible diagnosis in patients with symptoms of asthma.”

“The new recommendations will help health professionals provide the best possible care and treatment for the millions of people who struggle for breath every day as a result of exposure to substances in the work place.”

NOTES FOR EDITORS

The British Guideline on the Management of Asthma: Revised Edition November 2005 can be viewed on the SIGN and BTS websites at www.sign.ac.uk and www.brit-thoracic.org.uk

Areas covered: diagnosis and natural history; non-pharmacological management; pharmacological management; inhaler devices; management of acute asthma; asthma in pregnancy; occupational asthma; organisation and delivery of care; patient education and self-management; concordance and compliance; outcomes and audit.

The Scottish Intercollegiate Guidelines Network (SIGN) develops national clinical guidelines aimed at reducing variations in clinical practice and in outcomes for patients. Founded in 1993, SIGN became part of the national clinical effectiveness body, NHS Quality Improvement Scotland (NHS QIS) on 1 January 2005. NHS QIS oversees a range of complementary activities on translating research into practice, setting and monitoring standards, and promoting clinical excellence in NHSScotland.

The British Thoracic Society (BTS) is the UK’s professional body of respiratory specialists. The main aim of BTS is to improve the standards of care and treatment for patients with lung disease in the UK.

Self-management: prior to the update the guidelines already recommended that self-management education should be offered to all with asthma and the revised guidelines highlight that this has been shown to be advantageous even in those with milder disease, with the only exception being in those aged under 5 years. New self-management educational materials have been produced by Asthma UK and are themed under the title ‘Be In Control’: www.asthma.org.uk/about/control.php


BTS media contacts: Lauren Goddard or Alessandra Norman on 020 7815 3900
SIGN media contact: Patrick Maitland-Cullen on 07968 494 164

SIGN
28 Thistle Street
Edinburgh
EH2 1EN
www.sign.ac.uk

BTS
17 Doughty Street
London
WC1N 2PI
www.brit-thoracic.org.uk


ENDS